Seroquel, Quetiapine News

Raise your hand if you've breathed a sigh of relief seeing your doctor had a CME certificate next to the medical school diploma on the wall.

By Martha Rosenberg Page 1 of 2 page opednews.com Raise your hand if you've breathed a sign of relief seeing your doctor had a CME certificate next to the medical school diploma on the wall.

Speed freaks, coke heads, and antipsychotics. Last week, writing on the Daily Beast web site, reporter Jeff Deeney profiled a startling underground market for the antipsychotic medication Seroquel .

Up to one third of children and teens who took common antipsychotic drugs for the first time became overweight or obese in as little as 11 weeks, according to new research.

Researchers at Zucker Hillside Hospital in Glen Oaks NY have found a link to substantial weight gain and hypercholesterolemia in children and adolescents taking many common psychiatric medications.

Up to a third of children and adolescents who took common antipsychotic drugs for the first time became overweight or obese in as little as 11 weeks, raising their risk for diabetes and heart disease, U.S. researchers said Tuesday.

Children and teens who take medicines for conditions such as schizophrenia, bipolar disorder and autism tend to put on a substantial amount of weight, a new study finds.

Previous posts noted internal documents from AstraZeneca made public during litigation about its blockbuster atypical antipsychotic drug Seroquel suggesting that the company's marketers manipulated clinical research results to make them appear more favorable to the product, and suppress studies with unfavorable results that could not be easily ...

JERUSALEM A generic drug maker that a court of appeals upheld a decision regarding a patent of a popular antipsychotic medication.

Sep 25, 2009 - Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a July 1, 2008 decision by the District Court to grant AstraZeneca's motion for summary judgment of no inequitable conduct related to U.S. Patent No.

An argument could be made - and frequently has been made - that the off-label use of certain drugs in certain situations is a good thing.

This mistaken belief could encourage them to prescribe these drugs, despite the lack of scientific evidence supporting such use.

"Our research shows that some off-label prescribing might be driven by mistaken beliefs about FDA approval and the level of evidence supporting off-label drug use, " said G. Caleb Alexander, MD,... CHICAGO - In a recent national survey, a substantial minority of physicians erroneously believed that certain off-label uses of prescription drugs were ...

LAURENCE GREENHILL, MD Incoming head of AACAP An advisory committee to the Food and Drug Administration voted to approve two drugs for teens and pre-adolescents with schizophrenia and bipolar mania, and gave a split vote on a third drug.

LAURENCE GREENHILL, MD Incoming head of AACAP An advisory committee to the Food and Drug Administration voted to approve two drugs for teens and pre-adolescents with schizophrenia and bipolar mania, and gave a split vote on a third drug.

LAURENCE GREENHILL, MD Incoming head of AACAP An advisory committee to the Food and Drug Administration voted to approve two drugs for teens and pre-adolescents with schizophrenia and bipolar mania, and gave a split vote on a third drug.

Medical research out of the University of British Columbia suggests the number of children taking medications known as atypical antipsychotics has increased tenfold over the past decade, CBC News has learned.

Street drugs and dopamine theory overdoses: Furious Seasons has alerted me to an interesting article in the Boston Globe about street dealing of the antipsychotic drug quetiapine - interesting because it reveals some of our prejudices about the neuroscience of recreational drug use.

Seroquel debuted 12 years ago as a novel drug for adult patients with schizophrenia and bipolar disorder, a powerful pill that would help stabilize their emotional lives.

LONDON: Schizophrenia patients given a cheap, older drug are less likely to die prematurely than people on newer treatments, despite the older product's well-known adverse side effects, Finnish researchers said Monday.